Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial
| Image |  |
|---|---|
| Description | scholarly article by Ignacio Pérez-Valero et al published 11 June 2018 in Journal of Antimicrobial Chemotherapy |
| Author/s | |
| Publication date | June 11, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |